Andrographolide was reported to have immunoregulatory activities with different effects in different immune disease models, playing a role as a modulator of altered immune responses. In tumor- bearing mice it enhanced natural killer cell activity, increased secretion of IL-2 and IFN-γ by T cells and thereby inhibited the tumor growth.